Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue used to treat type 2 diabetes and obesity. des-6-Phe-SMT is an impurity that may be produced during the synthesis or degradation of semaglutide. Its structural feature is the missing phenylalanine (Phe) at position 6. This impurity may affect the purity and efficacy of the drug, so it needs to be strictly monitored in drug quality control.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
His-Ala-Glu-Gly-Thr-Thr-Ser-Asp-Val-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
Single letter sequence |
HAEGETTSDVYLGQAAKELIAWLVRGRG |
Molecular formula |
C177H257N45O54S |
Molecular weight |
4,035.9 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |